Doctor Admits of Leaking Safety Information to GSK

Posted on February 01, 2008 by MarkS

WASHINGTON, Jan. 30 — Citing a bad case of poor judgment, an independent reviewer for the New England Journal of Medicine has conceded that he leaked privileged information to GlaxoSmithKline last May on a meta-analysis that cast the company’s diabetes drug rosiglitazone (Avandia) in a bad light.

Learn More: Medpage Today

Filed under: Avandia, News, Pharma Co. Practice, Prescription Drugs, Regulation/Government | Tagged: , , , , , , ,

« More About Contaminated Drugs from China China Pesticide-Tainted Dumplings Poison 175 Japanese »

Leave a Reply

  • Add to Technorati Favorites
  • Health Blogs - Blog Catalog Blog Directory
  • Google Groups
    PharmaWatchDog
    Visit this group

  • Disclaimer

    Thank you for visiting my blog. This blog is for informational purposes only. None of the information at this website is intended to constitute, nor does it constitute, legal advice. This information is not intended to create an attorney-client relationship between me and the visitors of the PharmaWatchDog blog. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to particular factual or legal circumstances. Internet subscribers and online readers should not act on this information without seeking professional counsel.
  • hit counter